Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation elongation factor 1 beta 2 pseudogene 2 (EEF1B2P2) is a pseudogene related to the functional eukaryotic translation elongation factor genes, which encode key components of the eEF1 complex necessary for protein synthesis during the elongation step of translation. Unlike its functional counterparts (such as *EEF1B2*), EEF1B2P2 does not encode a functional protein. The biological function and disease associations of pseudogenes like EEF1B2P2 remain largely uncharacterized, and they are not considered therapeutic targets or biomarkers[1]. The main functional gene family (eEF1 complex) is essential for translation elongation, but EEF1B2P2 itself does not partake in these canonical roles and is generally not implicated in diseases or targeted by drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation elongation factor 1 beta 2 pseudogene 2 (EEF1B2P2).